A carregar...
Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
Portal vein embolization (PVE) for hepatocellular carcinoma (HCC) was first introduced in 1986 and has been continuously developed throughout the years. Basically, PVE has been applied to expand the indication of liver resection for HCC patients of insufficient future liver remnant. Importantly, PVE...
Na minha lista:
| Publicado no: | Ann Gastroenterol Surg |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164464/ https://ncbi.nlm.nih.gov/pubmed/34095718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12414 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|